nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ALB—lung cancer	0.226	1	CbGaD
Acenocoumarol—ORM1—Gefitinib—lung cancer	0.115	0.197	CbGbCtD
Acenocoumarol—ORM1—Erlotinib—lung cancer	0.0678	0.116	CbGbCtD
Acenocoumarol—ALB—Gefitinib—lung cancer	0.0482	0.0828	CbGbCtD
Acenocoumarol—CYP2C19—Gefitinib—lung cancer	0.0313	0.0537	CbGbCtD
Acenocoumarol—CYP2C19—Teniposide—lung cancer	0.0303	0.052	CbGbCtD
Acenocoumarol—ALB—Erlotinib—lung cancer	0.0285	0.0489	CbGbCtD
Acenocoumarol—CYP2C9—Gefitinib—lung cancer	0.026	0.0446	CbGbCtD
Acenocoumarol—ALB—Irinotecan—lung cancer	0.0258	0.0442	CbGbCtD
Acenocoumarol—CYP2C9—Teniposide—lung cancer	0.0252	0.0433	CbGbCtD
Acenocoumarol—CYP1A2—Erlotinib—lung cancer	0.0171	0.0293	CbGbCtD
Acenocoumarol—CYP3A4—Topotecan—lung cancer	0.0165	0.0284	CbGbCtD
Acenocoumarol—CYP3A4—Gefitinib—lung cancer	0.0151	0.0259	CbGbCtD
Acenocoumarol—CYP3A4—Teniposide—lung cancer	0.0147	0.0252	CbGbCtD
Acenocoumarol—CYP2C9—Paclitaxel—lung cancer	0.0141	0.0241	CbGbCtD
Acenocoumarol—ALB—Methotrexate—lung cancer	0.0136	0.0234	CbGbCtD
Acenocoumarol—CYP1A2—Etoposide—lung cancer	0.0123	0.0212	CbGbCtD
Acenocoumarol—CYP3A4—Vinorelbine—lung cancer	0.0116	0.02	CbGbCtD
Acenocoumarol—CYP2C9—Cisplatin—lung cancer	0.0113	0.0194	CbGbCtD
Acenocoumarol—CYP3A4—Crizotinib—lung cancer	0.00927	0.0159	CbGbCtD
Acenocoumarol—CYP3A4—Erlotinib—lung cancer	0.00894	0.0153	CbGbCtD
Acenocoumarol—CYP3A4—Paclitaxel—lung cancer	0.00818	0.014	CbGbCtD
Acenocoumarol—CYP3A4—Irinotecan—lung cancer	0.00807	0.0139	CbGbCtD
Acenocoumarol—CYP3A4—Vinblastine—lung cancer	0.00718	0.0123	CbGbCtD
Acenocoumarol—CYP3A4—Etoposide—lung cancer	0.00647	0.0111	CbGbCtD
Acenocoumarol—CYP3A4—Docetaxel—lung cancer	0.00592	0.0102	CbGbCtD
Acenocoumarol—Appetite absent—Gefitinib—lung cancer	0.00458	0.0389	CcSEcCtD
Acenocoumarol—CYP3A4—Doxorubicin—lung cancer	0.00441	0.00757	CbGbCtD
Acenocoumarol—Skin necrosis—Vinorelbine—lung cancer	0.00337	0.0286	CcSEcCtD
Acenocoumarol—Dicoumarol—NQO1—lung cancer	0.00258	0.515	CrCbGaD
Acenocoumarol—Skin necrosis—Cisplatin—lung cancer	0.00252	0.0214	CcSEcCtD
Acenocoumarol—Ulcer—Gefitinib—lung cancer	0.00241	0.0204	CcSEcCtD
Acenocoumarol—Skin necrosis—Etoposide—lung cancer	0.00231	0.0196	CcSEcCtD
Acenocoumarol—Skin necrosis—Paclitaxel—lung cancer	0.00227	0.0192	CcSEcCtD
Acenocoumarol—Melaena—Gefitinib—lung cancer	0.00222	0.0189	CcSEcCtD
Acenocoumarol—Skin exfoliation—Pemetrexed—lung cancer	0.00219	0.0186	CcSEcCtD
Acenocoumarol—Neoplasm—Teniposide—lung cancer	0.00168	0.0143	CcSEcCtD
Acenocoumarol—Skin necrosis—Methotrexate—lung cancer	0.00138	0.0118	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Erlotinib—lung cancer	0.00136	0.0116	CcSEcCtD
Acenocoumarol—Melaena—Erlotinib—lung cancer	0.00133	0.0113	CcSEcCtD
Acenocoumarol—Skin exfoliation—Erlotinib—lung cancer	0.0013	0.011	CcSEcCtD
Acenocoumarol—Neoplasm—Vinblastine—lung cancer	0.00128	0.0109	CcSEcCtD
Acenocoumarol—Neoplasm—Topotecan—lung cancer	0.00124	0.0106	CcSEcCtD
Acenocoumarol—Haematuria—Gefitinib—lung cancer	0.00121	0.0103	CcSEcCtD
Acenocoumarol—Skin necrosis—Doxorubicin—lung cancer	0.0012	0.0102	CcSEcCtD
Acenocoumarol—Haemoglobin—Gefitinib—lung cancer	0.00115	0.00976	CcSEcCtD
Acenocoumarol—Haemorrhage—Gefitinib—lung cancer	0.00114	0.00971	CcSEcCtD
Acenocoumarol—Skin exfoliation—Vinorelbine—lung cancer	0.00112	0.00954	CcSEcCtD
Acenocoumarol—Liver injury—Cisplatin—lung cancer	0.00105	0.00889	CcSEcCtD
Acenocoumarol—Ulcer—Irinotecan—lung cancer	0.00103	0.00871	CcSEcCtD
Acenocoumarol—Alopecia—Pemetrexed—lung cancer	0.00102	0.00864	CcSEcCtD
Acenocoumarol—Alopecia—Gefitinib—lung cancer	0.00101	0.00858	CcSEcCtD
Acenocoumarol—Ulcer—Gemcitabine—lung cancer	0.001	0.00849	CcSEcCtD
Acenocoumarol—Appetite absent—Methotrexate—lung cancer	0.000972	0.00825	CcSEcCtD
Acenocoumarol—Haemoglobin—Teniposide—lung cancer	0.000937	0.00796	CcSEcCtD
Acenocoumarol—Haemorrhage—Teniposide—lung cancer	0.000932	0.00792	CcSEcCtD
Acenocoumarol—Ulcer—Cisplatin—lung cancer	0.000932	0.00791	CcSEcCtD
Acenocoumarol—Skin exfoliation—Gemcitabine—lung cancer	0.000903	0.00767	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Cisplatin—lung cancer	0.000881	0.00748	CcSEcCtD
Acenocoumarol—Neoplasm—Irinotecan—lung cancer	0.000877	0.00745	CcSEcCtD
Acenocoumarol—Ulcer—Etoposide—lung cancer	0.000853	0.00725	CcSEcCtD
Acenocoumarol—Skin exfoliation—Cisplatin—lung cancer	0.000841	0.00715	CcSEcCtD
Acenocoumarol—Alopecia—Teniposide—lung cancer	0.000824	0.00699	CcSEcCtD
Acenocoumarol—Decreased appetite—Crizotinib—lung cancer	0.000778	0.0066	CcSEcCtD
Acenocoumarol—Melaena—Paclitaxel—lung cancer	0.000773	0.00657	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Crizotinib—lung cancer	0.000772	0.00656	CcSEcCtD
Acenocoumarol—Skin exfoliation—Etoposide—lung cancer	0.000771	0.00655	CcSEcCtD
Acenocoumarol—Skin exfoliation—Paclitaxel—lung cancer	0.000756	0.00642	CcSEcCtD
Acenocoumarol—Neoplasm—Paclitaxel—lung cancer	0.000716	0.00608	CcSEcCtD
Acenocoumarol—Haemoglobin—Vinblastine—lung cancer	0.000715	0.00607	CcSEcCtD
Acenocoumarol—Haemorrhage—Vinblastine—lung cancer	0.000711	0.00604	CcSEcCtD
Acenocoumarol—Decreased appetite—Pemetrexed—lung cancer	0.000711	0.00604	CcSEcCtD
Acenocoumarol—Body temperature increased—Crizotinib—lung cancer	0.000707	0.00601	CcSEcCtD
Acenocoumarol—Decreased appetite—Gefitinib—lung cancer	0.000706	0.006	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Pemetrexed—lung cancer	0.000706	0.00599	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gefitinib—lung cancer	0.000701	0.00596	CcSEcCtD
Acenocoumarol—Haemoglobin—Topotecan—lung cancer	0.000694	0.0059	CcSEcCtD
Acenocoumarol—Haemorrhage—Topotecan—lung cancer	0.000691	0.00587	CcSEcCtD
Acenocoumarol—Haemoglobin—Erlotinib—lung cancer	0.000687	0.00583	CcSEcCtD
Acenocoumarol—Haemorrhage—Erlotinib—lung cancer	0.000683	0.0058	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Docetaxel—lung cancer	0.000671	0.0057	CcSEcCtD
Acenocoumarol—Urticaria—Pemetrexed—lung cancer	0.000649	0.00552	CcSEcCtD
Acenocoumarol—Body temperature increased—Pemetrexed—lung cancer	0.000646	0.00549	CcSEcCtD
Acenocoumarol—Urticaria—Gefitinib—lung cancer	0.000645	0.00548	CcSEcCtD
Acenocoumarol—Body temperature increased—Gefitinib—lung cancer	0.000642	0.00545	CcSEcCtD
Acenocoumarol—Skin exfoliation—Docetaxel—lung cancer	0.000641	0.00544	CcSEcCtD
Acenocoumarol—Alopecia—Vinblastine—lung cancer	0.000628	0.00534	CcSEcCtD
Acenocoumarol—Diarrhoea—Crizotinib—lung cancer	0.000612	0.0052	CcSEcCtD
Acenocoumarol—Alopecia—Topotecan—lung cancer	0.00061	0.00518	CcSEcCtD
Acenocoumarol—Neoplasm—Docetaxel—lung cancer	0.000607	0.00515	CcSEcCtD
Acenocoumarol—Flunitrazepam—UGT1A1—lung cancer	0.000605	0.121	CrCbGaD
Acenocoumarol—Alopecia—Erlotinib—lung cancer	0.000604	0.00513	CcSEcCtD
Acenocoumarol—Hypersensitivity—Pemetrexed—lung cancer	0.000602	0.00512	CcSEcCtD
Acenocoumarol—Hypersensitivity—Gefitinib—lung cancer	0.000598	0.00508	CcSEcCtD
Acenocoumarol—Decreased appetite—Teniposide—lung cancer	0.000576	0.00489	CcSEcCtD
Acenocoumarol—Vomiting—Crizotinib—lung cancer	0.000569	0.00483	CcSEcCtD
Acenocoumarol—Dermatitis—Crizotinib—lung cancer	0.000563	0.00479	CcSEcCtD
Acenocoumarol—Diarrhoea—Pemetrexed—lung cancer	0.000559	0.00475	CcSEcCtD
Acenocoumarol—Diarrhoea—Gefitinib—lung cancer	0.000556	0.00472	CcSEcCtD
Acenocoumarol—Nausea—Crizotinib—lung cancer	0.000531	0.00451	CcSEcCtD
Acenocoumarol—Urticaria—Teniposide—lung cancer	0.000526	0.00447	CcSEcCtD
Acenocoumarol—Body temperature increased—Teniposide—lung cancer	0.000523	0.00445	CcSEcCtD
Acenocoumarol—Alopecia—Vinorelbine—lung cancer	0.000522	0.00444	CcSEcCtD
Acenocoumarol—Vomiting—Pemetrexed—lung cancer	0.00052	0.00441	CcSEcCtD
Acenocoumarol—Vomiting—Gefitinib—lung cancer	0.000516	0.00439	CcSEcCtD
Acenocoumarol—Dermatitis—Pemetrexed—lung cancer	0.000515	0.00437	CcSEcCtD
Acenocoumarol—Dermatitis—Gefitinib—lung cancer	0.000512	0.00435	CcSEcCtD
Acenocoumarol—Ulcer—Methotrexate—lung cancer	0.000511	0.00434	CcSEcCtD
Acenocoumarol—Haematuria—Gemcitabine—lung cancer	0.000504	0.00428	CcSEcCtD
Acenocoumarol—Liver injury—Doxorubicin—lung cancer	0.000498	0.00423	CcSEcCtD
Acenocoumarol—Haemoglobin—Irinotecan—lung cancer	0.00049	0.00416	CcSEcCtD
Acenocoumarol—Hypersensitivity—Teniposide—lung cancer	0.000488	0.00414	CcSEcCtD
Acenocoumarol—Haemorrhage—Irinotecan—lung cancer	0.000487	0.00414	CcSEcCtD
Acenocoumarol—Nausea—Pemetrexed—lung cancer	0.000486	0.00412	CcSEcCtD
Acenocoumarol—Nausea—Gefitinib—lung cancer	0.000482	0.0041	CcSEcCtD
Acenocoumarol—Haemoglobin—Gemcitabine—lung cancer	0.000477	0.00405	CcSEcCtD
Acenocoumarol—Haemorrhage—Gemcitabine—lung cancer	0.000475	0.00403	CcSEcCtD
Acenocoumarol—Melaena—Methotrexate—lung cancer	0.000472	0.00401	CcSEcCtD
Acenocoumarol—Skin exfoliation—Methotrexate—lung cancer	0.000462	0.00392	CcSEcCtD
Acenocoumarol—Diarrhoea—Teniposide—lung cancer	0.000453	0.00385	CcSEcCtD
Acenocoumarol—Ulcer—Doxorubicin—lung cancer	0.000443	0.00376	CcSEcCtD
Acenocoumarol—Decreased appetite—Vinblastine—lung cancer	0.000439	0.00373	CcSEcCtD
Acenocoumarol—Neoplasm—Methotrexate—lung cancer	0.000437	0.00371	CcSEcCtD
Acenocoumarol—Alopecia—Irinotecan—lung cancer	0.000431	0.00366	CcSEcCtD
Acenocoumarol—Decreased appetite—Topotecan—lung cancer	0.000427	0.00362	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Topotecan—lung cancer	0.000424	0.0036	CcSEcCtD
Acenocoumarol—Haematuria—Paclitaxel—lung cancer	0.000422	0.00359	CcSEcCtD
Acenocoumarol—Decreased appetite—Erlotinib—lung cancer	0.000422	0.00359	CcSEcCtD
Acenocoumarol—Vomiting—Teniposide—lung cancer	0.000421	0.00358	CcSEcCtD
Acenocoumarol—Alopecia—Gemcitabine—lung cancer	0.00042	0.00356	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Erlotinib—lung cancer	0.000419	0.00356	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Doxorubicin—lung cancer	0.000419	0.00356	CcSEcCtD
Acenocoumarol—Dermatitis—Teniposide—lung cancer	0.000417	0.00354	CcSEcCtD
Acenocoumarol—Melaena—Doxorubicin—lung cancer	0.000409	0.00347	CcSEcCtD
Acenocoumarol—Skin exfoliation—Doxorubicin—lung cancer	0.0004	0.0034	CcSEcCtD
Acenocoumarol—Haemoglobin—Paclitaxel—lung cancer	0.0004	0.00339	CcSEcCtD
Acenocoumarol—Haemorrhage—Paclitaxel—lung cancer	0.000397	0.00338	CcSEcCtD
Acenocoumarol—Nausea—Teniposide—lung cancer	0.000393	0.00334	CcSEcCtD
Acenocoumarol—Alopecia—Cisplatin—lung cancer	0.000391	0.00332	CcSEcCtD
Acenocoumarol—Urticaria—Topotecan—lung cancer	0.00039	0.00331	CcSEcCtD
Acenocoumarol—Body temperature increased—Topotecan—lung cancer	0.000388	0.0033	CcSEcCtD
Acenocoumarol—Body temperature increased—Erlotinib—lung cancer	0.000384	0.00326	CcSEcCtD
Acenocoumarol—Flunitrazepam—CYP2A6—lung cancer	0.00038	0.076	CrCbGaD
Acenocoumarol—Neoplasm—Doxorubicin—lung cancer	0.000379	0.00322	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vinblastine—lung cancer	0.000372	0.00316	CcSEcCtD
Acenocoumarol—Warfarin—CYP1A1—lung cancer	0.000365	0.073	CrCbGaD
Acenocoumarol—Decreased appetite—Vinorelbine—lung cancer	0.000365	0.0031	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000362	0.00308	CcSEcCtD
Acenocoumarol—Hypersensitivity—Topotecan—lung cancer	0.000362	0.00307	CcSEcCtD
Acenocoumarol—Alopecia—Etoposide—lung cancer	0.000358	0.00304	CcSEcCtD
Acenocoumarol—Alopecia—Paclitaxel—lung cancer	0.000351	0.00298	CcSEcCtD
Acenocoumarol—Diarrhoea—Vinblastine—lung cancer	0.000346	0.00294	CcSEcCtD
Acenocoumarol—Haemoglobin—Docetaxel—lung cancer	0.000339	0.00288	CcSEcCtD
Acenocoumarol—Haemorrhage—Docetaxel—lung cancer	0.000337	0.00286	CcSEcCtD
Acenocoumarol—Diarrhoea—Topotecan—lung cancer	0.000336	0.00285	CcSEcCtD
Acenocoumarol—Urticaria—Vinorelbine—lung cancer	0.000334	0.00283	CcSEcCtD
Acenocoumarol—Diarrhoea—Erlotinib—lung cancer	0.000332	0.00282	CcSEcCtD
Acenocoumarol—Body temperature increased—Vinorelbine—lung cancer	0.000332	0.00282	CcSEcCtD
Acenocoumarol—Vomiting—Vinblastine—lung cancer	0.000321	0.00273	CcSEcCtD
Acenocoumarol—Vomiting—Topotecan—lung cancer	0.000312	0.00265	CcSEcCtD
Acenocoumarol—Hypersensitivity—Vinorelbine—lung cancer	0.000309	0.00263	CcSEcCtD
Acenocoumarol—Dermatitis—Topotecan—lung cancer	0.000309	0.00263	CcSEcCtD
Acenocoumarol—Vomiting—Erlotinib—lung cancer	0.000309	0.00262	CcSEcCtD
Acenocoumarol—Dermatitis—Erlotinib—lung cancer	0.000306	0.0026	CcSEcCtD
Acenocoumarol—Decreased appetite—Irinotecan—lung cancer	0.000301	0.00256	CcSEcCtD
Acenocoumarol—Nausea—Vinblastine—lung cancer	0.0003	0.00255	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Irinotecan—lung cancer	0.000299	0.00254	CcSEcCtD
Acenocoumarol—Alopecia—Docetaxel—lung cancer	0.000298	0.00253	CcSEcCtD
Acenocoumarol—Decreased appetite—Gemcitabine—lung cancer	0.000293	0.00249	CcSEcCtD
Acenocoumarol—Nausea—Topotecan—lung cancer	0.000292	0.00248	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000291	0.00247	CcSEcCtD
Acenocoumarol—Nausea—Erlotinib—lung cancer	0.000288	0.00245	CcSEcCtD
Acenocoumarol—Diarrhoea—Vinorelbine—lung cancer	0.000287	0.00244	CcSEcCtD
Acenocoumarol—Body temperature increased—Irinotecan—lung cancer	0.000274	0.00232	CcSEcCtD
Acenocoumarol—Decreased appetite—Cisplatin—lung cancer	0.000273	0.00232	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Cisplatin—lung cancer	0.000271	0.00231	CcSEcCtD
Acenocoumarol—Flunitrazepam—CYP2E1—lung cancer	0.00027	0.054	CrCbGaD
Acenocoumarol—Vomiting—Vinorelbine—lung cancer	0.000267	0.00227	CcSEcCtD
Acenocoumarol—Body temperature increased—Gemcitabine—lung cancer	0.000267	0.00226	CcSEcCtD
Acenocoumarol—Dermatitis—Vinorelbine—lung cancer	0.000264	0.00225	CcSEcCtD
Acenocoumarol—Haematuria—Methotrexate—lung cancer	0.000258	0.00219	CcSEcCtD
Acenocoumarol—Hypersensitivity—Irinotecan—lung cancer	0.000255	0.00217	CcSEcCtD
Acenocoumarol—Decreased appetite—Etoposide—lung cancer	0.00025	0.00213	CcSEcCtD
Acenocoumarol—Nausea—Vinorelbine—lung cancer	0.000249	0.00212	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Etoposide—lung cancer	0.000249	0.00211	CcSEcCtD
Acenocoumarol—Body temperature increased—Cisplatin—lung cancer	0.000249	0.00211	CcSEcCtD
Acenocoumarol—Decreased appetite—Paclitaxel—lung cancer	0.000245	0.00208	CcSEcCtD
Acenocoumarol—Haemoglobin—Methotrexate—lung cancer	0.000244	0.00207	CcSEcCtD
Acenocoumarol—Nitrazepam—CYP2E1—lung cancer	0.000244	0.0487	CrCbGaD
Acenocoumarol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000244	0.00207	CcSEcCtD
Acenocoumarol—Haemorrhage—Methotrexate—lung cancer	0.000243	0.00206	CcSEcCtD
Acenocoumarol—Diarrhoea—Irinotecan—lung cancer	0.000237	0.00201	CcSEcCtD
Acenocoumarol—Hypersensitivity—Cisplatin—lung cancer	0.000232	0.00197	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemcitabine—lung cancer	0.000231	0.00196	CcSEcCtD
Acenocoumarol—Phenprocoumon—ALB—lung cancer	0.000229	0.0458	CrCbGaD
Acenocoumarol—Urticaria—Etoposide—lung cancer	0.000229	0.00194	CcSEcCtD
Acenocoumarol—Body temperature increased—Etoposide—lung cancer	0.000228	0.00193	CcSEcCtD
Acenocoumarol—Urticaria—Paclitaxel—lung cancer	0.000224	0.00191	CcSEcCtD
Acenocoumarol—Haematuria—Doxorubicin—lung cancer	0.000223	0.0019	CcSEcCtD
Acenocoumarol—Body temperature increased—Paclitaxel—lung cancer	0.000223	0.0019	CcSEcCtD
Acenocoumarol—Vomiting—Irinotecan—lung cancer	0.00022	0.00187	CcSEcCtD
Acenocoumarol—Dermatitis—Irinotecan—lung cancer	0.000218	0.00185	CcSEcCtD
Acenocoumarol—Diarrhoea—Cisplatin—lung cancer	0.000215	0.00183	CcSEcCtD
Acenocoumarol—Alopecia—Methotrexate—lung cancer	0.000215	0.00182	CcSEcCtD
Acenocoumarol—Vomiting—Gemcitabine—lung cancer	0.000214	0.00182	CcSEcCtD
Acenocoumarol—Dermatitis—Gemcitabine—lung cancer	0.000212	0.0018	CcSEcCtD
Acenocoumarol—Hypersensitivity—Etoposide—lung cancer	0.000212	0.0018	CcSEcCtD
Acenocoumarol—Haemoglobin—Doxorubicin—lung cancer	0.000211	0.00179	CcSEcCtD
Acenocoumarol—Haemorrhage—Doxorubicin—lung cancer	0.00021	0.00179	CcSEcCtD
Acenocoumarol—Decreased appetite—Docetaxel—lung cancer	0.000208	0.00177	CcSEcCtD
Acenocoumarol—Hypersensitivity—Paclitaxel—lung cancer	0.000208	0.00177	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Docetaxel—lung cancer	0.000207	0.00176	CcSEcCtD
Acenocoumarol—Nausea—Irinotecan—lung cancer	0.000206	0.00175	CcSEcCtD
Acenocoumarol—Warfarin—ALB—lung cancer	0.000203	0.0407	CrCbGaD
Acenocoumarol—Nausea—Gemcitabine—lung cancer	0.0002	0.0017	CcSEcCtD
Acenocoumarol—Vomiting—Cisplatin—lung cancer	0.0002	0.0017	CcSEcCtD
Acenocoumarol—Dermatitis—Cisplatin—lung cancer	0.000198	0.00168	CcSEcCtD
Acenocoumarol—Diarrhoea—Etoposide—lung cancer	0.000197	0.00167	CcSEcCtD
Acenocoumarol—Diarrhoea—Paclitaxel—lung cancer	0.000193	0.00164	CcSEcCtD
Acenocoumarol—Body temperature increased—Docetaxel—lung cancer	0.000189	0.00161	CcSEcCtD
Acenocoumarol—Nausea—Cisplatin—lung cancer	0.000187	0.00159	CcSEcCtD
Acenocoumarol—Alopecia—Doxorubicin—lung cancer	0.000186	0.00158	CcSEcCtD
Acenocoumarol—Vomiting—Etoposide—lung cancer	0.000183	0.00156	CcSEcCtD
Acenocoumarol—Dermatitis—Etoposide—lung cancer	0.000181	0.00154	CcSEcCtD
Acenocoumarol—Vomiting—Paclitaxel—lung cancer	0.00018	0.00152	CcSEcCtD
Acenocoumarol—Dermatitis—Paclitaxel—lung cancer	0.000178	0.00151	CcSEcCtD
Acenocoumarol—Hypersensitivity—Docetaxel—lung cancer	0.000176	0.0015	CcSEcCtD
Acenocoumarol—Nausea—Etoposide—lung cancer	0.000171	0.00145	CcSEcCtD
Acenocoumarol—Nausea—Paclitaxel—lung cancer	0.000168	0.00142	CcSEcCtD
Acenocoumarol—Diarrhoea—Docetaxel—lung cancer	0.000164	0.00139	CcSEcCtD
Acenocoumarol—Vomiting—Docetaxel—lung cancer	0.000152	0.00129	CcSEcCtD
Acenocoumarol—Dermatitis—Docetaxel—lung cancer	0.000151	0.00128	CcSEcCtD
Acenocoumarol—Decreased appetite—Methotrexate—lung cancer	0.00015	0.00127	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Methotrexate—lung cancer	0.000149	0.00126	CcSEcCtD
Acenocoumarol—Nausea—Docetaxel—lung cancer	0.000142	0.00121	CcSEcCtD
Acenocoumarol—Urticaria—Methotrexate—lung cancer	0.000137	0.00116	CcSEcCtD
Acenocoumarol—Body temperature increased—Methotrexate—lung cancer	0.000136	0.00116	CcSEcCtD
Acenocoumarol—Decreased appetite—Doxorubicin—lung cancer	0.00013	0.0011	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000129	0.0011	CcSEcCtD
Acenocoumarol—Nitrazepam—ABCB1—lung cancer	0.000128	0.0256	CrCbGaD
Acenocoumarol—Hypersensitivity—Methotrexate—lung cancer	0.000127	0.00108	CcSEcCtD
Acenocoumarol—Urticaria—Doxorubicin—lung cancer	0.000119	0.00101	CcSEcCtD
Acenocoumarol—Body temperature increased—Doxorubicin—lung cancer	0.000118	0.001	CcSEcCtD
Acenocoumarol—Diarrhoea—Methotrexate—lung cancer	0.000118	0.001	CcSEcCtD
Acenocoumarol—Hypersensitivity—Doxorubicin—lung cancer	0.00011	0.000935	CcSEcCtD
Acenocoumarol—Vomiting—Methotrexate—lung cancer	0.00011	0.000932	CcSEcCtD
Acenocoumarol—Dermatitis—Methotrexate—lung cancer	0.000109	0.000923	CcSEcCtD
Acenocoumarol—Nausea—Methotrexate—lung cancer	0.000102	0.00087	CcSEcCtD
Acenocoumarol—Diarrhoea—Doxorubicin—lung cancer	0.000102	0.000868	CcSEcCtD
Acenocoumarol—Vomiting—Doxorubicin—lung cancer	9.5e-05	0.000807	CcSEcCtD
Acenocoumarol—Dermatitis—Doxorubicin—lung cancer	9.41e-05	0.000799	CcSEcCtD
Acenocoumarol—Nausea—Doxorubicin—lung cancer	8.87e-05	0.000754	CcSEcCtD
Acenocoumarol—CYP2C9—Metabolism—ABCC3—lung cancer	1.32e-05	0.000193	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ADCY1—lung cancer	1.32e-05	0.000192	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCG2—lung cancer	1.32e-05	0.000192	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GNG11—lung cancer	1.32e-05	0.000192	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.31e-05	0.000191	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HPGDS—lung cancer	1.29e-05	0.000189	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ENO2—lung cancer	1.29e-05	0.000189	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CD—lung cancer	1.28e-05	0.000188	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPP2R1B—lung cancer	1.28e-05	0.000188	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AKR1C1—lung cancer	1.28e-05	0.000187	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CNDP2—lung cancer	1.27e-05	0.000186	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM2—lung cancer	1.27e-05	0.000186	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.27e-05	0.000185	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTT1—lung cancer	1.25e-05	0.000183	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALDOA—lung cancer	1.25e-05	0.000183	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—B4GALT5—lung cancer	1.25e-05	0.000183	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—UGT1A1—lung cancer	1.24e-05	0.000182	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GCLC—lung cancer	1.24e-05	0.000181	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP2A6—lung cancer	1.24e-05	0.000181	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTMR3—lung cancer	1.24e-05	0.000181	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.23e-05	0.00018	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTA4—lung cancer	1.22e-05	0.000178	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NCOA3—lung cancer	1.22e-05	0.000178	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PGAM1—lung cancer	1.21e-05	0.000176	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GNG11—lung cancer	1.2e-05	0.000175	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.19e-05	0.000175	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.19e-05	0.000174	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.19e-05	0.000174	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTA2—lung cancer	1.18e-05	0.000173	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ADCY1—lung cancer	1.18e-05	0.000173	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCG2—lung cancer	1.18e-05	0.000173	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ENO1—lung cancer	1.17e-05	0.000172	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.17e-05	0.000171	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.17e-05	0.000171	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ENO2—lung cancer	1.16e-05	0.000169	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HPGDS—lung cancer	1.16e-05	0.000169	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.15e-05	0.000168	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2A7—lung cancer	1.15e-05	0.000168	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—RAF1—lung cancer	1.15e-05	0.000168	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTA1—lung cancer	1.14e-05	0.000167	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALDOA—lung cancer	1.14e-05	0.000167	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.14e-05	0.000166	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCC3—lung cancer	1.13e-05	0.000165	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SDC4—lung cancer	1.13e-05	0.000165	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTT1—lung cancer	1.12e-05	0.000164	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CB—lung cancer	1.12e-05	0.000164	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GCLC—lung cancer	1.11e-05	0.000162	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP2A6—lung cancer	1.11e-05	0.000162	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NCOA3—lung cancer	1.11e-05	0.000162	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.11e-05	0.000162	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AKR1C1—lung cancer	1.09e-05	0.00016	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.09e-05	0.000159	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.08e-05	0.000158	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCG2—lung cancer	1.08e-05	0.000158	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ADCY1—lung cancer	1.08e-05	0.000158	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—UGT1A1—lung cancer	1.06e-05	0.000155	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HPGDS—lung cancer	1.06e-05	0.000154	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ENO2—lung cancer	1.06e-05	0.000154	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ENO1—lung cancer	1.05e-05	0.000154	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000154	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.05e-05	0.000154	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.05e-05	0.000153	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NQO1—lung cancer	1.04e-05	0.000152	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.04e-05	0.000151	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.04e-05	0.000151	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IL2—lung cancer	1.03e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTA3—lung cancer	1.03e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—RRM1—lung cancer	1.03e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTT1—lung cancer	1.03e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GNG11—lung cancer	1.02e-05	0.00015	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.02e-05	0.000149	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.02e-05	0.000149	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP2A6—lung cancer	1.01e-05	0.000148	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GCLC—lung cancer	1.01e-05	0.000148	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.01e-05	0.000148	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.01e-05	0.000148	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	9.93e-06	0.000145	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALDOA—lung cancer	9.76e-06	0.000143	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—B4GALT5—lung cancer	9.65e-06	0.000141	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ENO1—lung cancer	9.61e-06	0.00014	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.58e-06	0.00014	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NCOA3—lung cancer	9.47e-06	0.000138	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP2E1—lung cancer	9.45e-06	0.000138	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.45e-06	0.000138	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—STK11—lung cancer	9.39e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTA4—lung cancer	9.38e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NQO1—lung cancer	9.35e-06	0.000137	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.31e-06	0.000136	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—EP300—lung cancer	9.23e-06	0.000135	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ADCY1—lung cancer	9.21e-06	0.000135	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCG2—lung cancer	9.21e-06	0.000135	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.15e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTA2—lung cancer	9.14e-06	0.000134	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.07e-06	0.000132	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HPGDS—lung cancer	9.04e-06	0.000132	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ENO2—lung cancer	9.04e-06	0.000132	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPP2R1B—lung cancer	8.98e-06	0.000131	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—SRC—lung cancer	8.98e-06	0.000131	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.86e-06	0.000129	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTA1—lung cancer	8.82e-06	0.000129	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.81e-06	0.000129	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTT1—lung cancer	8.76e-06	0.000128	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VEGFA—lung cancer	8.74e-06	0.000128	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCC3—lung cancer	8.72e-06	0.000127	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTP1—lung cancer	8.69e-06	0.000127	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP2A6—lung cancer	8.66e-06	0.000127	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GCLC—lung cancer	8.66e-06	0.000127	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—NRAS—lung cancer	8.63e-06	0.000126	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.63e-06	0.000126	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP2E1—lung cancer	8.62e-06	0.000126	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NQO1—lung cancer	8.52e-06	0.000125	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CAT—lung cancer	8.45e-06	0.000123	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AKR1C1—lung cancer	8.45e-06	0.000123	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—STK11—lung cancer	8.43e-06	0.000123	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.4e-06	0.000123	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.35e-06	0.000122	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.27e-06	0.000121	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MAPK3—lung cancer	8.27e-06	0.000121	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCB1—lung cancer	8.22e-06	0.00012	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ENO1—lung cancer	8.21e-06	0.00012	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—UGT1A1—lung cancer	8.2e-06	0.00012	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.18e-06	0.00012	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.08e-06	0.000118	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TYMS—lung cancer	8.07e-06	0.000118	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTM1—lung cancer	7.98e-06	0.000117	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.91e-06	0.000116	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GNG11—lung cancer	7.91e-06	0.000116	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTP1—lung cancer	7.8e-06	0.000114	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—STK11—lung cancer	7.68e-06	0.000112	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CAT—lung cancer	7.59e-06	0.000111	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP1A1—lung cancer	7.57e-06	0.000111	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.54e-06	0.00011	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALDOA—lung cancer	7.53e-06	0.00011	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ERCC2—lung cancer	7.5e-06	0.00011	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—KRAS—lung cancer	7.43e-06	0.000109	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCB1—lung cancer	7.38e-06	0.000108	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP2E1—lung cancer	7.37e-06	0.000108	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NCOA3—lung cancer	7.31e-06	0.000107	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NQO1—lung cancer	7.28e-06	0.000106	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TYMS—lung cancer	7.25e-06	0.000106	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.21e-06	0.000105	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTM1—lung cancer	7.16e-06	0.000105	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.13e-06	0.000104	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ADCY1—lung cancer	7.11e-06	0.000104	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCG2—lung cancer	7.11e-06	0.000104	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTP1—lung cancer	7.11e-06	0.000104	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.07e-06	0.000103	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ENO2—lung cancer	6.97e-06	0.000102	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HPGDS—lung cancer	6.97e-06	0.000102	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPP2R1B—lung cancer	6.93e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CAT—lung cancer	6.92e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.88e-06	0.0001	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CA—lung cancer	6.83e-06	9.97e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP1A1—lung cancer	6.79e-06	9.92e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTT1—lung cancer	6.76e-06	9.88e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ERCC2—lung cancer	6.74e-06	9.84e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCB1—lung cancer	6.73e-06	9.83e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GCLC—lung cancer	6.69e-06	9.77e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2A6—lung cancer	6.69e-06	9.77e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TYMS—lung cancer	6.61e-06	9.65e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TP53—lung cancer	6.61e-06	9.65e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—STK11—lung cancer	6.57e-06	9.59e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTM1—lung cancer	6.53e-06	9.54e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APOA1—lung cancer	6.49e-06	9.48e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ENO1—lung cancer	6.34e-06	9.26e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—HRAS—lung cancer	6.32e-06	9.23e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.22e-06	9.08e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP1A1—lung cancer	6.19e-06	9.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.16e-06	9e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ERCC2—lung cancer	6.14e-06	8.97e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTP1—lung cancer	6.07e-06	8.87e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CG—lung cancer	5.93e-06	8.66e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CAT—lung cancer	5.91e-06	8.64e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.88e-06	8.59e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APOA1—lung cancer	5.83e-06	8.51e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCB1—lung cancer	5.75e-06	8.4e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2E1—lung cancer	5.69e-06	8.3e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TYMS—lung cancer	5.65e-06	8.25e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—POMC—lung cancer	5.64e-06	8.24e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NQO1—lung cancer	5.62e-06	8.21e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTM1—lung cancer	5.58e-06	8.16e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.58e-06	8.15e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—AKT1—lung cancer	5.58e-06	8.15e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CREBBP—lung cancer	5.49e-06	8.03e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CG—lung cancer	5.32e-06	7.77e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOA1—lung cancer	5.31e-06	7.76e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP1A1—lung cancer	5.29e-06	7.73e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ERCC2—lung cancer	5.25e-06	7.67e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CD—lung cancer	5.21e-06	7.61e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.09e-06	7.43e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—STK11—lung cancer	5.07e-06	7.4e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—POMC—lung cancer	5.06e-06	7.4e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CREBBP—lung cancer	4.93e-06	7.21e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CG—lung cancer	4.85e-06	7.09e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTP1—lung cancer	4.69e-06	6.85e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CD—lung cancer	4.68e-06	6.83e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—POMC—lung cancer	4.62e-06	6.75e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALB—lung cancer	4.62e-06	6.74e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CAT—lung cancer	4.56e-06	6.66e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CB—lung cancer	4.54e-06	6.63e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOA1—lung cancer	4.54e-06	6.63e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS2—lung cancer	4.5e-06	6.57e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CREBBP—lung cancer	4.5e-06	6.57e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCB1—lung cancer	4.44e-06	6.48e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TYMS—lung cancer	4.36e-06	6.37e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.35e-06	6.35e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM1—lung cancer	4.31e-06	6.29e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CD—lung cancer	4.26e-06	6.23e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALB—lung cancer	4.21e-06	6.15e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CG—lung cancer	4.15e-06	6.06e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP1A1—lung cancer	4.08e-06	5.97e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CB—lung cancer	4.08e-06	5.96e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ERCC2—lung cancer	4.05e-06	5.92e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS2—lung cancer	4.04e-06	5.9e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—POMC—lung cancer	3.95e-06	5.76e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTEN—lung cancer	3.92e-06	5.73e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CREBBP—lung cancer	3.84e-06	5.61e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—EP300—lung cancer	3.74e-06	5.47e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CB—lung cancer	3.72e-06	5.43e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS2—lung cancer	3.68e-06	5.38e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CD—lung cancer	3.64e-06	5.32e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALB—lung cancer	3.6e-06	5.26e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTEN—lung cancer	3.52e-06	5.15e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOA1—lung cancer	3.5e-06	5.12e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—EP300—lung cancer	3.36e-06	4.91e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTEN—lung cancer	3.21e-06	4.69e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CG—lung cancer	3.2e-06	4.67e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CB—lung cancer	3.18e-06	4.64e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS2—lung cancer	3.15e-06	4.6e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—EP300—lung cancer	3.06e-06	4.47e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—POMC—lung cancer	3.05e-06	4.45e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CREBBP—lung cancer	2.97e-06	4.33e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CD—lung cancer	2.81e-06	4.11e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALB—lung cancer	2.78e-06	4.06e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CA—lung cancer	2.77e-06	4.04e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTEN—lung cancer	2.74e-06	4.01e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—EP300—lung cancer	2.62e-06	3.82e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CA—lung cancer	2.49e-06	3.63e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CB—lung cancer	2.45e-06	3.58e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS2—lung cancer	2.43e-06	3.55e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CA—lung cancer	2.27e-06	3.31e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AKT1—lung cancer	2.26e-06	3.3e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTEN—lung cancer	2.12e-06	3.09e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AKT1—lung cancer	2.03e-06	2.97e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—EP300—lung cancer	2.02e-06	2.95e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CA—lung cancer	1.94e-06	2.83e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AKT1—lung cancer	1.85e-06	2.7e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AKT1—lung cancer	1.58e-06	2.31e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CA—lung cancer	1.49e-06	2.18e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AKT1—lung cancer	1.22e-06	1.78e-05	CbGpPWpGaD
